| |
| |
|
| Insider
Information: |
Wentworth Kerry |
| Relationship: |
Chief Regulatory Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
57,410 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,461 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,410 |
|
|
| Total
Value |
$25,461 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -91.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agenus Inc |
AGEN |
VP, Clinical, Reg & Qual |
2014-02-26 |
57,410 |
|
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Chief Regulatory Officer |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2018-10-06 |
4/A |
OE |
$0.00 |
$0 |
D/D |
3,400 |
15,878 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2019-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,400 |
54,396 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2011-12-21 |
4 |
S |
$2.24 |
$7,641 |
D/D |
(3,414) |
32,067 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2020-01-03 |
4 |
S |
$0.00 |
$0 |
D/D |
(3,724) |
50,061 |
0 |
% |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-04-26 |
4 |
AS |
$1.21 |
$5,059 |
D/D |
(4,165) |
140,539 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-07-26 |
4 |
AS |
$0.80 |
$3,330 |
D/D |
(4,165) |
140,541 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-10-26 |
4 |
AS |
$0.97 |
$4,040 |
D/D |
(4,165) |
144,088 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-10-26 |
4 |
A |
$0.98 |
$4,082 |
D/D |
4,165 |
148,253 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg & Quality |
• – – |
2011-07-26 |
4 |
A |
$0.79 |
$3,291 |
D/D |
4,166 |
203,716 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-04-26 |
4 |
A |
$1.19 |
$4,959 |
D/D |
4,167 |
144,704 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2010-07-26 |
4 |
A |
$0.79 |
$3,292 |
D/D |
4,167 |
144,706 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2011-01-26 |
4 |
A |
$0.95 |
$3,959 |
D/D |
4,167 |
177,150 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2011-04-26 |
4 |
A |
$0.92 |
$3,834 |
D/D |
4,167 |
199,550 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clin, Reg & Quality |
• – – |
2009-09-10 |
4 |
A |
$2.40 |
$12,000 |
D/D |
5,000 |
107,799 |
0 |
- |
|
| AGEN |
Agenus Inc |
Vp, Clin, Reg & Quality |
• – – |
2010-09-10 |
4 |
A |
$0.93 |
$4,650 |
D/D |
5,000 |
145,541 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg & Quality |
• – – |
2011-09-12 |
4 |
A |
$0.55 |
$2,750 |
D/D |
5,000 |
208,716 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg & Qual |
• – – |
2014-02-26 |
4 |
AS |
$5.00 |
$25,000 |
D/D |
(5,000) |
57,410 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Clinical, Reg & Quality |
• – – |
2012-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,044 |
36,021 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-11-19 |
4 |
D |
$8.50 |
$51,000 |
I/I |
(6,000) |
0 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP, Clinical, Reg, & Quality |
• – – |
2012-03-15 |
4 |
A |
$5.31 |
$32,269 |
D/D |
6,077 |
44,370 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2008-07-10 |
4 |
D |
$1.76 |
$11,181 |
D/D |
(6,353) |
24,672 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Regulatory Officer |
• – – |
2021-01-05 |
4 |
S |
$11.13 |
$76,007 |
D/D |
(6,829) |
113,767 |
0 |
% |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2009-01-10 |
4 |
D |
$0.46 |
$3,607 |
D/D |
(7,842) |
46,172 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Affairs & Clinical Ops |
• – – |
2008-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,906 |
8,467 |
0 |
- |
|
| AGEN |
Agenus Inc |
VP Reg Aff and Clinical Ops |
• – – |
2009-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
7,907 |
32,579 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
